
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Cascade amplification of therapeutic payloads for cancer immunotherapy - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5312CF8AEF2E830512CF000707E95C.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="commbiol">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Communications Biology">
<meta name="citation_title" content="Cascade amplification of therapeutic payloads for cancer immunotherapy">
<meta name="citation_author" content="Yingzhong Li">
<meta name="citation_author_institution" content="SunVax mRNA Therapeutics, Inc, Beverly, MA USA">
<meta name="citation_author" content="Jiayu Wu">
<meta name="citation_author_institution" content="SunVax mRNA Therapeutics, Inc, Beverly, MA USA">
<meta name="citation_author" content="Na Li">
<meta name="citation_author_institution" content="SunVax mRNA Therapeutics, Inc, Beverly, MA USA">
<meta name="citation_author" content="Maoqing Wu">
<meta name="citation_author_institution" content="SunVax mRNA Therapeutics, Inc, Beverly, MA USA">
<meta name="citation_author" content="Zongqi Wang">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, College of Engineering and School of Medicine, University of Michigan, Ann Arbor, MI USA">
<meta name="citation_author" content="Jiahe Li">
<meta name="citation_author_institution" content="Department of Biomedical Engineering, College of Engineering and School of Medicine, University of Michigan, Ann Arbor, MI USA">
<meta name="citation_author" content="Libin Zhang">
<meta name="citation_author_institution" content="SunVax mRNA Therapeutics, Inc, Beverly, MA USA">
<meta name="citation_publication_date" content="2025 Aug 25">
<meta name="citation_volume" content="8">
<meta name="citation_firstpage" content="1277">
<meta name="citation_doi" content="10.1038/s42003-025-08735-z">
<meta name="citation_pmid" content="40851032">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/pdf/42003_2025_Article_8735.pdf">
<meta name="description" content="Achieving sufficient therapeutic payload delivery remains a significant challenge in gene therapy, particularly for cancer immunotherapy, where payload thresholds are critical for efficacy. To address this, we developed a Cascade Amplification of ...">
<meta name="og:title" content="Cascade amplification of therapeutic payloads for cancer immunotherapy">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Achieving sufficient therapeutic payload delivery remains a significant challenge in gene therapy, particularly for cancer immunotherapy, where payload thresholds are critical for efficacy. To address this, we developed a Cascade Amplification of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12375736">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s42003-025-08735-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/42003_2025_Article_8735.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12375736%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12375736/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12375736/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-commbiol.jpg" alt="Communications Biology logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Communications Biology" title="Link to Communications Biology" shape="default" href="https://www.nature.com/commsbio/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Commun Biol</button></div>. 2025 Aug 25;8:1277. doi: <a href="https://doi.org/10.1038/s42003-025-08735-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s42003-025-08735-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Commun%20Biol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Commun%20Biol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Commun%20Biol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Commun%20Biol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Cascade amplification of therapeutic payloads for cancer immunotherapy</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yingzhong Li</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yingzhong Li</span></h3>
<div class="p">
<sup>1</sup>SunVax mRNA Therapeutics, Inc, Beverly, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yingzhong Li</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Jiayu Wu</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Jiayu Wu</span></h3>
<div class="p">
<sup>1</sup>SunVax mRNA Therapeutics, Inc, Beverly, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiayu Wu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Na Li</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Na Li</span></h3>
<div class="p">
<sup>1</sup>SunVax mRNA Therapeutics, Inc, Beverly, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Na Li</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Maoqing Wu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Maoqing Wu</span></h3>
<div class="p">
<sup>1</sup>SunVax mRNA Therapeutics, Inc, Beverly, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maoqing Wu</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Zongqi Wang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Zongqi Wang</span></h3>
<div class="p">
<sup>2</sup>Department of Biomedical Engineering, College of Engineering and School of Medicine, University of Michigan, Ann Arbor, MI USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zongqi Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jiahe Li</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jiahe Li</span></h3>
<div class="p">
<sup>2</sup>Department of Biomedical Engineering, College of Engineering and School of Medicine, University of Michigan, Ann Arbor, MI USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiahe Li</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Libin Zhang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Libin Zhang</span></h3>
<div class="p">
<sup>1</sup>SunVax mRNA Therapeutics, Inc, Beverly, MA USA </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Libin Zhang</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>SunVax mRNA Therapeutics, Inc, Beverly, MA USA </div>
<div id="Aff2">
<sup>2</sup>Department of Biomedical Engineering, College of Engineering and School of Medicine, University of Michigan, Ann Arbor, MI USA </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 6; Accepted 2025 Aug 18; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12375736  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40851032/" class="usa-link">40851032</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Achieving sufficient therapeutic payload delivery remains a significant challenge in gene therapy, particularly for cancer immunotherapy, where payload thresholds are critical for efficacy. To address this, we developed a Cascade Amplification of Therapeutic Payloads (CATP) system, leveraging lipid nanoparticles (LNPs) to co-deliver self-amplifying mRNA (SamRNA) and modified mRNA encoding alphavirus capsids and envelopes. The CATP system initiates a dual-amplification process: SamRNA amplifies therapeutic payloads within transfected cells, while capsid and envelope proteins package SamRNA into defective viral particles to infect neighboring cells, enabling secondary payload amplification. This single-cycle infection ensures enhanced efficacy while maintaining safety. In vitro and in vivo studies demonstrated the CATP system’s superiority over conventional SamRNA delivery. In a B16F10 melanoma model, CATP achieved a 525-fold increase in intratumoral IL-12 levels, resulting in tumor regression and long-term immune memory. The platform also showed broad applicability, effectively treating MC38 colorectal cancer, CT26 colon cancer, and <em>P53</em><sup><em>null</em></sup>
<em>Kras</em><sup><em>G12D</em></sup> pancreatic ductal adenocarcinoma. Additionally, optimization of therapeutic payloads with mutant IL-18 further enhanced anti-tumor efficacy. The CATP system represents a transformative approach to gene therapy, providing a scalable, safe, and potent platform for cancer immunotherapy. Its dual-amplification strategy offers new opportunities for overcoming payload limitations across diverse malignancies.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Cancer immunotherapy, Synthetic biology, Translational immunology</p></section></section><section class="abstract" id="Abs2"><hr class="headless">
<p id="Par2">A Cascade Amplification of Therapeutic Payloads, by co-delivery of self-amplifying mRNA and modified mRNA encoding alphavirus capsids and envelopes, realizes hundred times increases of expression by same dosage, broadening therapeutic applications.</p></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">Messenger RNA (mRNA) has emerged as a transformative platform for therapeutic applications, leveraging its potential for transient, tunable protein expression. Among its various forms, modified mRNA, circular mRNA, and self-amplifying mRNA (SamRNA), SamRNA has garnered significant attention due to its capacity for intracellular amplifications to increase protein expression, enabling therapeutic efficacy at substantially lower initial doses compared to conventional mRNA<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>,<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. However, mRNA inherently act as a pathogen-associated molecular patterns (PAMP) that can be recognized by endosomal sensors, such as Toll-like receptors 3 (TLR3) or 7 (TLR7), as well as cytosol sensors, including MDA5 or RIG1. Activation of these receptors and/or sensors triggers the release of interferons resulting in fevers, local and systemic inflammation as well as other side effects<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. Though various strategies have been developed such as modification of uridine and other nucleotides<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>, as well as mimicking native mRNA caps<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>, to reduce the stimulations of interferon responses, the side effects, including fever, remain a common challenge. For example, the side effects during the clinical applications of COVID 19 vaccines are highly relevant to the dosage levels and the extent of interferon induction<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>.</p>
<p id="Par4">Thus, there is an urgent need for a novel modality that maintains low mRNA dosage while dramatically increasing therapeutic payloads to reduce the mRNA-associated cytotoxicity and broaden its therapeutic application<sup><a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. To address these challenges, we introduce the Cascade Amplification of Therapeutic Payloads (CATP) system, a groundbreaking platform that leverages SamRNA to encode therapeutic payloads, initiating a first wave of therapeutic payload expression. Simultaneously, the system co-delivers modified mRNA encoding viral capsid and envelope proteins which generate defective viral particles to achieve a second wave of therapeutic payload expression. This dual-amplification mechanism offers a highly effective solution for gene therapies and cancer immunotherapies. As a proof of concept, we employed IL-12 as the initial therapeutic payload, given its extensive evaluation in preclinical studies and advancement into clinical trials<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>–<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>, thereby enhancing the translational potential of the CATP system for clinical applications.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">In vitro and in vivo validation of cascade amplification of therapeutic payloads (CATP)</h3>
<p id="Par5">To overcome the limitations of existing mRNA and SamRNA approaches, which often require increased dosages or frequent administrations, we introduce a novel strategy to amplify therapeutic payloads in vivo without escalating the dosage. By co-delivering SamRNA from Venezuelan equine encephalitis (VEE) encoding therapeutic payloads and modified mRNA encoding optimized viral capsids/envelop using lipid nanoparticles, the inherent amplification of SamRNA generated the first wave of therapeutic payloads produced in transfected cells. Meanwhile, the translated capsid and envelop proteins in transfected cells package SamRNA and produce defective yet infectious viral particles<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup> to transduce adjacent cells with SamRNA, further amplifying the therapeutic payloads and enhancing overall efficacy (Fig. <a href="#Fig1" class="usa-link">1a, b</a>). We refer to this new technology as cascade amplification of therapeutic payloads (CATP) in this work. Importantly, since the mRNA encoding capsids/envelop is not encapsulated in the viral genome, the infection is restricted to a single cycle, thereby ensuring safety.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Cascade amplifications of therapeutic payloads encoding mouse IL-12 on B16F10 melanoma therapy.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12375736_42003_2025_8735_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67d/12375736/51834f8f7a35/42003_2025_8735_Fig1_HTML.jpg" loading="lazy" id="d33e296" height="692" width="800" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong> Illustration of the cascade amplification of therapeutic payloads (CATP) was created in BioRender. Li, Y. (2025) <a href="https://BioRender.com/g50p020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/g50p020</a>. <strong>b</strong> Illustrations of constructs for CATP. <strong>c</strong> Effects of CATP in HEK293 cells. HEK293 cells were treated by LNP encapsulated SamRNA mRNA encoding with eGFP and modified mRNA encoding with envelop and capsids from VEE or LNP encapsulated SamRNA mRNA encoding with eGFP and modified mRNA encoding firefly luciferase. Then the GFP percentages were determined by flow cytometer at days 1, 2, 3, and 4 post transfection. The shown are the changes of GFP versus days post transfection. <strong>d</strong> Scheme of tumor inoculation and treatment: Six- to eight-week-old C57BL/6 mice (<em>n</em> = 5 per group, a cage of animal) were subcutaneously inoculated with 1 million B16F10 melanoma cells. Seven days post-inoculation, mice were intratumorally treated with PBS (Control group of basal line), or LNP encapsulating 10 µg SamRNA encoding with mouse IL-12 (mIL-12) and 1 µg modified mRNA encoding with firefly luciferase (Control group of treated group) or LNP encapsulated 10 µg of SamRNA encoding mIL-12<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup> and 1 µg modified mRNA encoding capsids/envelops from VEE, following the principle that molar ratio of modified mRNA (1 µg) is smaller than it of samRNA (10 µg). <strong>e</strong> mIL-12 expression in sera and tumors. The <em>P</em>-Values labeled in <strong>e</strong> were determined by Tukey’s multiple comparisons test.</p></figcaption></figure><p id="Par6">To validate our platform in vitro, HEK293 cells were co-transfected with SamRNA encoding eGFP and modified mRNA encoding VEE capsids/envelop (CATP: Sam(eGFP)_mod(<em>VEE</em>)) and were compared to cells transfected with SamRNA encoding eGFP (Contr: Sam(eGFP)_mod(<em>Luci</em>). As anticipated, the percentages of eGFP-positive cells were initially lower in the CATP group than the control group within the first three days post transfection. However, eGFP-positive cells in the CATP group markedly expanded on day 3 and surpassed those in the control group after day 4. In contrast, the control group started to decay after day 2 (Fig. <a href="#Fig1" class="usa-link">1c</a>). To track the function of the defective viruses, the naive HEK293 cells were incubated with the supernatants of the cells treated with CATP: Sam(eGFP)_mod(<em>VEE</em>), or Contr: Sam(eGFP)_mod(<em>Luci</em>), or PBS. A day post incubation, the CATP group showed clear GFP populations, indicating the formations of defective VEE viral particles (Supplementary Fig. <a href="#MOESM2" class="usa-link">1a</a>). This observation underscored the key feature of CATP in terms of amplifying reporter genes in vitro.</p>
<p id="Par7">Further validation of the amplification capacity of CATP was performed in a highly immune resistant mouse B16F10 melanoma model<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup> via a single intratumoral<sup><a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup> injection of lipid nanoparticles encapsulating CATP encoding mouse cytokine IL-12<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>. Delivery of recombinant IL-12 via different technologies has been shown to exhibit potent anti-tumor immunity by stimulating CD4, CD8 T cells, NK cells, and B cells, while its prolonged systemic exposure is associated with host toxicity. To track the function of the defective viruses, the naive HEK293 cells were incubated with the supernatants of the cells treated with CATP: Sam(<em>IL-12</em>)_mod(<em>VEE</em>), or Contr: Sam(<em>IL-12</em>)_mod(<em>Luci</em>), or PBS. Two days post incubation, the CATP group showed 64% more of IL-12 expression, indicating the formations of defective VEE viral particles encoding mouse <em>IL-12</em> and enhancing the IL-12 expression (Supplementary Fig. <a href="#MOESM2" class="usa-link">1b</a>). Compared to the control group containing SamRNA encoding mouse IL-12 (Contr: Sam(<em>IL-12</em>)_mod(<em>Luci</em>)), the CATP group containing SamRNA-IL12 and VEE capsids/envelop (CATP: Sam(<em>IL-12</em>)_mod(<em>VEE</em>)) displayed five-fold increase in mouse serum IL-12 levels on day 1, remained detectable on day 3, and became undetectable by day 7. Notably, the mouse IL-12 levels in tumor sites increased by 525 times in CATP group relative to that of control group (Fig. <a href="#Fig1" class="usa-link">1d, e</a>). These results demonstrated that the CATP system outperformed the conventional SamRNA platforms in the expression of transgenes both in vitro and in vivo, though the outperformances by CATP are much faster in vivo.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Enhanced therapeutic efficacy of CATP-mIL-12 in the B16F10 melanoma model</h3>
<p id="Par8">We further evaluate whether the increased therapeutic levels achieved through a single dose of CATP-mIL-12 improves therapeutic efficacies in the B16F10 melanoma model that’s a poorly immunogenic and highly aggressive model for cancer immunotherapy<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. On day 7 post-inoculation of cancer cells when tumor areas reached approximately 50 mm<sup>2</sup>, mice were intratumorally treated with a single dose of CATP or corresponding controls as described in Fig. <a href="#Fig1" class="usa-link">1d</a>. Consistent with the increased therapeutic levels observed in Fig. <a href="#Fig1" class="usa-link">1e</a>, tumors in the CATP-IL-12 group showed improved regression (Fig. <a href="#Fig2" class="usa-link">2a</a>), resulting in 40% of fully tumor regressed mice (<em>p</em> = 0.0357, Fig. <a href="#Fig2" class="usa-link">2b</a>). Notably, body weight changes were minimal at 3% (Fig. <a href="#Fig2" class="usa-link">2c</a>), aligning with the undetectable serum IL-12 levels on day 7 post injections of LNP-mRNA (Fig. <a href="#Fig1" class="usa-link">1e</a>). In summary, the CATP not only increases the expression of therapeutic payloads but also enhances therapeutic efficacy while maintaining the same dosage and safety profiles, demonstrating its potential as a safe and effective cancer immunotherapy strategy.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. In vivo synthesis of defective viruses significantly enhances therapeutic efficacy against B16F10 melanoma.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12375736_42003_2025_8735_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67d/12375736/626a1be50019/42003_2025_8735_Fig2_HTML.jpg" loading="lazy" id="d33e429" height="234" width="772" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Six- to eight-week-old C57BL/6 mice (<em>n</em> = 5 per group, a cage of animal) were subcutaneously inoculated with 1 million B16F10 melanoma cells. Seven days post-inoculation, mice were intratumorally treated with PBS (Control group of basal line), or LNP encapsulating 10 µg SamRNA encoding with mouse IL-12 (IL-12) and 1 µg modified mRNA encoding with firefly luciferase (Control group of treated group) or LNP encapsulated 10 µg of SamRNA encoding IL-12 and 1 µg modified mRNA encoding capsids/envelops from VEE. Results are shown as: Tumor areas (Y-axis), Survival rates (Y-axis), and Body weight changes (Y-axis) versus days post-B16F10 melanoma cell inoculation (X-axis) <strong>a</strong>, <strong>b</strong>, and <strong>c</strong>, respectively. The <em>P</em>-Values label in <strong>b</strong> were determined by a Comparison of Survival Curves (Kaper-myer) test.</p></figcaption></figure></section><section id="Sec5"><h3 class="pmc_sec_title">Comparative analysis of capsids and envelopes for optimizing CATP therapeutic efficacy</h3>
<p id="Par9">To investigate the roles of different capsids/envelops in determining the amplification efficiency for CATP, we evaluated capsids/envelops derived from three commonly used alphaviruses, including VEE, Sindbis virus (SIN), and Semliki Forest virus (SFV4)<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. Interestingly, the SFV4-derived capsids/envelops exhibited the strongest regression of tumor growth (Fig. <a href="#Fig3" class="usa-link">3a</a>), resulting in a 60% fully tumor regressed rate with minimal weight changes (Fig. <a href="#Fig3" class="usa-link">3b, c</a>). These findings suggest that CATP leveraging SFV4 capsids/envelops may generate oncolytic virus-like particles (Fig. <a href="#Fig3" class="usa-link">3d</a>), in agreement with other researchers’ observations of oncolytic effects associated with SFV4 viruses<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. The oncolytic viral effects will be helpful to release the tumor associated antigens (TAA) and trigger the inflammasomes along with the LNP-mRNA, which are critical prime immune responses against tumor as in the Fig. <a href="#Fig3" class="usa-link">3b, d</a>.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. Comparison of therapeutic efficacies by CATP with VEE, SIN, and SFV4 capsids/envelop.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12375736_42003_2025_8735_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67d/12375736/b41a630bd762/42003_2025_8735_Fig3_HTML.jpg" loading="lazy" id="d33e505" height="666" width="800" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Six- to eight-week-old C57BL/6 mice (<em>n</em> = 5 per group, a cage of animal) were subcutaneously inoculated with 1 million B16F10 melanoma cells. Seven days post-inoculation, mice were intratumorally treated with PBS (Control group of basal line), or LNP encapsulated 10 µg of SamRNA encoding mIL-12 and 1 µg modified mRNA encoding capsids/envelops from VEE (Control group of treated group), SIN, and SFV4 as indicated. Results are shown as: Tumor areas (<em>Y</em>-axis), Survival rates (<em>Y</em>-axis), and Body weight changes (<em>Y</em>-axis) versus days post-B16F10 cell inoculation (<em>X</em>-axis) (<strong>a</strong>, <strong>b</strong>, <strong>c</strong>), respectively. <strong>d</strong> Illustrations of CATP with oncolytic effects by the capsids/envelop such as SFV4 was created in BioRender. Li, Y. (2025) <a href="https://BioRender.com/bguaszo" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/bguaszo</a>. The SamRNA, regular mRNA, therapeutic payloads, capsids/envelop, defective viruses, tumor associated antigens (TAA), and inflammasomes triggered by defective viruses and LNP-mRNA are indicated. The <em>P</em>-Values labeled in <strong>a</strong> and <strong>c</strong> were determined by a two-way ANOVA test and Comparison of Survival Curves (Kaper-myer) test.</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">Optimization of combinatorial cytokines for CATP therapy in multiple tumor models</h3>
<p id="Par10">To further enhance therapeutic efficacy, we optimized therapeutic payloads by combining mouse IL-12 with mouse IL-18, as IL-18 enhances polarizations towards Type 1 inflammation in the presence of IL-12<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>,<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. However, IL-18 binding protein (IL-18BP) has been reported to be upregulated in solid tumors thereby inhibiting IL-18 activity<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. Therefore, we compared wildtype mouse IL-18 to a mutant form, which was designed to disrupt interactions with IL-18BP<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>.</p>
<p id="Par11">Following a single dosing in tumors with a starting size of ~50 mm<sup>2</sup>, the combination of mIL-12 with mutant mIL-18 in the CATP system significantly inhibited the tumor growth and increased the fully tumor regressed rates to 80% in the B16F10 melanoma model. This outcome markedly surpassed the 40% fully tumor regressed rates achieved by mIL-12 plus wild-type mIL-18, or mIL-12 alone (Fig. <a href="#Fig4" class="usa-link">4a, b</a>). While the CATP with mouse mutant IL-18 alone effectively inhibited tumor growth, it failed to fully suppress any tumor-bearing mouse (Fig. <a href="#Fig4" class="usa-link">4a, b</a>), indicating that the anti-tumor effects of mutant IL-18 were dependent on mouse IL-12. Although the combination of mIL-12 with mutant mIL-18 was initially associated with body weight loss of &gt; 6% after CATP administration, they returned to normal body weights similar to the control group (PBS) one week after the dosing (14 days post tumor inoculation, <em>p</em> = 0.8421) (Fig. <a href="#Fig4" class="usa-link">4c</a>). These findings suggest that the CATP system combining mIL-12 and mutant IL-18 displayed superior efficacy without compromising the safety following a single administration in tumors.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. Optimization of therapeutic payloads of CATP in B16F10 melanoma model.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12375736_42003_2025_8735_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67d/12375736/3633fe08a283/42003_2025_8735_Fig4_HTML.jpg" loading="lazy" id="d33e576" height="302" width="800" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Six- to eight-week-old C57BL/6 mice (<em>n</em> = 5 per group, a cage of animal) were subcutaneously inoculated with 1 million B16F10 melanoma cells. Seven days post-inoculation, mice were intratumorally treated with PBS (Control group of basal line), or LNP encapsulating 5 µg SamRNA encoding with mouse IL-12 (IL-12), 5 µg SamRNA encoding with firefly Luciferase, and 1 µg modified mRNA encoding capsids/envelops from SFV4 (Control group of treated group); or LNP encapsulating 5 µg SamRNA encoding with mouse wild type IL-18 (wtIL-18) or mutant IL-18 (mtIL-18), 5 µg SamRNA encoding with firefly Luciferase, and 1 µg modified mRNA encoding capsids/envelops from SFV4; or LNP encapsulating 5 µg SamRNA encoding with mouse IL-12 (IL-12), 5 µg SamRNA encoding with wild type IL-18 (wtIL-18) or mutant IL-18 (mtIL-18), and 1 µg modified mRNA encoding capsids/envelops from SFV4 as indicated. Results are shown as: Tumor areas (Y-axis), Survival rates (<em>Y</em>-axis), and Body weight changes (<em>Y</em>-axis) versus days post B16F10 melanoma cell inoculation (<em>X</em>-axis) (<strong>a</strong><strong>–</strong><strong>c</strong>), respectively. The <em>P</em>-Values labeled was determined by a two-way ANOVA test or Comparison of Survival Curves (Kaper-myer) test.</p></figcaption></figure><p id="Par12">To generalize the CATP system to other syngeneic mouse cancer models, we next evaluated the MC38 colorectal cancer model and demonstrated that the CATP therapy combing mIL-12 and mutant mIL-18 fully suppressed all the tumors (Supplementary Fig. <a href="#MOESM2" class="usa-link">2a, b</a>). Furthermore, in the CT26 colon cancer model, the CATP therapy with mIL-12 and mutant mIL18 achieved 80% fully tumor regressed rates, outperforming 20% fully tumor regressed rates with CATP mIL-12 alone (Supplementary Fig. <a href="#MOESM2" class="usa-link">3a, b</a>). There is no significant difference between the body weights of CATP therapy combing mIL-12 and mutant mIL-18 group and the control group (PBS) one week after the dosing (Supplementary Figs. <a href="#MOESM2" class="usa-link">2c</a>, <a href="#MOESM2" class="usa-link">3c</a>).</p></section><section id="Sec7"><h3 class="pmc_sec_title">CATP-mediated delivery of mIL-12 and mutant IL-18 in <em>P53</em><sup><em>null</em></sup><em>Kras</em><sup><em>G12D</em></sup> pancreatic cancer</h3>
<p id="Par13">To assess the efficacy of this approach in genetically driven cancers, mice were subcutaneously inoculated with <em>P53</em><sup><em>null</em></sup>
<em>Kras</em><sup><em>G12D</em></sup> pancreatic duct cancer<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup> cells and treated intratumorally. Consistent with previous findings, the CATP combination therapy with mIL-12 and mutant mIL-18 resulted in better inhibition of tumor growth and 80% of mice being fully tumor regressed, compared to 60% with IL-12 alone (Fig. <a href="#Fig5" class="usa-link">5a–c</a>). In summary, CATP combining IL-12 and mutant IL-18 demonstrates superior efficacy across multiple cancer models. Moreover, no overt body weight differences were detected between the combination and the vehicle control group (PBS) one week after dosing, although the combination treatment was associated with an initial decrease in body weight within 2–3 days after dosing (Supplementary Figs. <a href="#MOESM2" class="usa-link">2c</a>, <a href="#MOESM2" class="usa-link">3c</a> and  Fig. <a href="#Fig5" class="usa-link">5c</a>).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5. Therapeutic efficacy of CATP with optimized therapeutic payloads and SFV4 capsids in KPC (<em>P53</em><sup><em>null</em></sup><em>KRas</em><sup><em>G12D</em></sup>) pancreatic duct cancer model.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12375736_42003_2025_8735_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67d/12375736/d985a8938ec2/42003_2025_8735_Fig5_HTML.jpg" loading="lazy" id="d33e701" height="235" width="791" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Six- to eight-week-old C57BL/6 mice (<em>n</em> = 5 per group, a cage of animal) were subcutaneously inoculated with cancer cells as indicated. Seven days post inoculation, the tumor was intratumorally treated with the LNP encapsulated with mRNA as indicated, with PBS (Control group of basal line), or LNP encapsulating 5 µg SamRNA encoding with mouse IL-12 (IL-12), 5 µg SamRNA encoding with firefly Luciferase, and 1 µg modified mRNA encoding capsids/envelops from SFV4 (Control group of treated group); or LNP encapsulating 5 µg SamRNA encoding with mouse IL-12 (IL-12), 5 µg SamRNA encoding with mutant IL-18 (mtIL-18), and 1 µg modified mRNA encoding capsids/envelops from SFV4. Results are shown as: Tumor areas (<em>Y</em>-axis), Survival rates (<em>Y</em>-axis), and Body weight changes (<em>Y</em>-axis) versus days post KPC (<em>P53</em><sup><em>null</em></sup>
<em>KRas</em><sup><em>G12D</em></sup>) pancreatic duct cancer cell inoculation (<em>X</em>-axis) (<strong>a</strong><strong>–</strong><strong>c</strong>), respectively. The <em>P</em>-Values labeled in <strong>a</strong> and <strong>b</strong> were determined by a two-way ANOVA test or Comparison of Survival Curves (Kaper-myer) test.</p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">Induction of long-term immune memory by CATP therapy against tumor recurrence</h3>
<p id="Par14">To determine whether fully tumor regressed mice treated with the CATP combination therapy developed long-term immune memory in B16F10 and MC38 models, we rechallenged the treated mice with original tumor cells, which more than 75 days. Of note, all fully tumor regressed mice were able to reject the tumor cells, in contrast to the age- and sex-matched naïve mice that developed tumors (Fig. <a href="#Fig6" class="usa-link">6a, b</a> and Supplementary Fig. <a href="#MOESM2" class="usa-link">4a, b</a>). These results suggested that the CATP system induces robust long-term immune memory. To investigate the mechanisms underlying this immune memory, we intratumorally treated B16F10 melanoma with the CATP therapy using mouse IL-12 alone (Fig. <a href="#Fig6" class="usa-link">6c</a>). Flow cytometry analysis of tumor draining lymph nodes (TDLNs) and spleen showed that the CATP group significantly (<em>p</em> = 0.0006) increased the number of memory precursor CD8 T cells characterized by CD62L<sup>+</sup> CD122<sup>+</sup> over the control group in TDLNs despite no significant difference between the two groups in spleens<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>,<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup> (Fig. <a href="#Fig6" class="usa-link">6d, e</a> and Supplementary Fig. <a href="#MOESM2" class="usa-link">5</a>). Additionally, no significant differences were observed in CD62L<sup>-</sup> KLRG1<sup>+</sup> cytotoxic CD8 T cells either in TDLN or in spleen (Fig. <a href="#Fig6" class="usa-link">6e</a>)<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>. These findings suggested that the CATP therapy is likely to expand the population of memory precursor CD8 T cells in TDLNs, contributing to long term protection against tumor recurrence.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6. CATP with mouse IL-12 and mutant IL-18 induces long-term immune memory against tumor recurrences.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12375736_42003_2025_8735_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f67d/12375736/8d3f9950d8d8/42003_2025_8735_Fig6_HTML.jpg" loading="lazy" id="d33e818" height="505" width="800" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a, b</strong> Re-challenges of fully tumor regressed mice in the group LNP encapsulated 5 µg of SamRNA encoding with mouse mutant IL-18 plus 5 µg of SamRNA encoding mouse IL-12 and 1 µg of modified mRNA encoding with SFV4 capsids/envelop proteins. The treated mice (<em>n</em> = 10) and naïve mice (<em>n</em> = 7, Control group) matched with age and sex and were challenged with 0.1 million B16F10 cells. Results are shown as: Tumor areas (Y-axis) and Survival rates (<em>Y</em>-axis) versus days post B16F10 melanoma cancer cell inoculation (X-axis). <strong>c</strong> Scheme of tumor inoculation and treatment. <strong>d</strong>, <strong>e</strong> Phenotyping of memory precursor of CD8 T cells and cytotoxic CD8 T cells in spleen. Six- to eight-week-old C57BL/6 mice (n = 5 per group, a cage of animal) were subcutaneously inoculated with 1 million B16F10 cells. Seven days post-inoculation, mice received a single intratumorally injection of PBS (Control group of basal line), LNP encapsulated 10 µg of SamRNA encoding with mIL-12 and 1 µg of modified mRNA encoding with luciferase (Control group of treated group) or LNP encapsulated 10 µg SamRNA encoding with mIL-12 and 1 µg of modified mRNA encoding VEE capsids and envelop proteins. On day 7 injections of LNP-mRNA, the mice were sacrificed. Shown are the numerates of the CD8<sup>+</sup> CD62L<sup>+</sup> CD122<sup>+</sup> and CD8<sup>+</sup> CD62L<sup>-</sup> KLRG1<sup>+</sup> in draining lymph nodes (DLN) (<strong>d</strong>) and spleens (<strong>e</strong>), respectively. The <em>P</em>-Values labeled in <strong>a</strong>, <strong>b</strong>, <strong>d</strong> were determined by a two-way ANOVA test for <strong>a</strong> Comparison of Survival Curves (Kaper-myer) test for <strong>b</strong> or a two-way ANOVA test for <strong>d</strong>.</p></figcaption></figure></section></section><section id="Sec9"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par15">The Cascade Amplification of Therapeutic Payloads (CATP) system presented in this study introduces a transformative approach to addressing the persistent challenge of insufficient therapeutic payload delivery in cancer therapy. Utilizing a dual-amplification mechanism that combines SamRNA with modified mRNA, the CATP system demonstrates remarkable efficiency in amplifying therapeutic proteins both in vitro and in vivo. This innovative strategy holds significant promise for cancer immunotherapy, enabling higher therapeutic efficacy at a single dosage, thereby mitigating toxicity concerns commonly associated with conventional mRNA and SamRNA therapies.</p>
<p id="Par16">The B16F10 melanoma mouse model results demonstrated the CATP system’s exceptional capacity to achieve a 525-fold increase in intratumoral IL-12 levels compared to controls. This remarkable amplification underscores the robustness of the CATP platform and its potential to overcome critical limitations of existing gene therapy approaches, which often rely on escalating dosages to achieve therapeutic efficacy. Crucially, the transient nature of CATP-driven IL-12 expression ensures minimal systemic exposure, thereby substantially mitigating the risk of off-target effects and toxicity. This represents a notable advancement over current IL-12 delivery strategies, which have historically been hindered due to systemic toxicity in clinical settings<sup><a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>.</p>
<p id="Par17">The CATP platform was successfully extended beyond IL-12 to incorporate a combination of IL-12 and mutant IL-18, achieving synergistic anti-tumor effects across multiple cancer models, including B16F10 melanoma, MC38 colorectal cancer, CT26 colon cancer, and <em>P53</em><sup><em>null</em></sup>
<em>KRas</em><sup><em>G12D</em></sup> pancreatic ductal cancer. The incorporation of mutant IL-18, which resists inhibition by IL-18BP, exemplifies the platform’s adaptability and its potential for rational therapeutic payload design to maximize efficacy. Notably, the 80% fully tumor regressed survival rate observed across diverse mouse tumor models highlights the broad applicability of the CATP platform, positioning it as a versatile and powerful tool in cancer immunotherapy.</p>
<p id="Par18">The findings further indicate that the therapeutic efficacy of the CATP system is significantly influenced by the selection of viral capsid/envelop protein. For instance, constructs utilizing capsids derived from SFV4 exhibited superior tumor regression and survival outcomes compared to those derived employing capsids from VEE or Sindbis virus. These results underscore the importance of optimizing viral components to enhance the efficiency and therapeutic potential of the CATP system, offering a promising avenue for further development.</p>
<p id="Par19">An additional compelling aspect of the CATP system is its capacity to induce robust long-term immune memory, evidenced by the successful rejection of tumor rechallenges in treated mice. This phenomenon is attributed to the expansion of memory precursor CD8 T cells in tumor-draining lymph nodes, a key feature that may provide durable protection against tumor recurrence. This immunological advantage further strengthens the therapeutic potential of CATP system, positioning it as a long-term prevention of relapse.</p>
<p id="Par20">The further compelling aspect of the CATP system lies in its capability to achieve potent therapeutic efficacies through the combination of IL-12 and mutant IL-18 without the need for immune checkpoint blockade (ICB) therapies, such as anti-PD1 or anti-PD-L1, as utilized in clinical trials <a href="https://clinicaltrials.gov/ct2/show/NCT03946800" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03946800</a> and <a href="https://clinicaltrials.gov/ct2/show/NCT03871348" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03871348</a>. This distinction is critical, as ICB therapies may limit the capacity of rejuvenated cells to generate long-lived antitumor immunity following tumor clearance<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a></sup>. Additionally, CATP treatment requires only a single administration, unlike alternative approaches such as those in <a href="https://clinicaltrials.gov/ct2/show/NCT03871348" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT03871348</a><sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>, which involve multiple injections. These repeated treatments risk continuous antigen stimulations and subsequent exhaustion of tumor specific CD8 T cells<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>.</p>
<p id="Par21">In this work, the CATP system was administrated intratumorally.The advantages of intratumourally injections with therapeutic agents (e.g., CATP, LNP-mRNA encoding with therapeutic) could enhance antitumour immune responses, reduce the risk of systemic toxicities, and achieve higher local bioactive drug concentrations, which was widely validated in preclinical and clinical practices<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>,<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>. The intatumorally injection is powerful to be used for those tumors easier to reach, such as melanoma, breast cancer, head-neck cancer, colon cancers et al. However, intatumorally injection is very difficult to touch those deeper tumors, limiting its applications.</p>
<p id="Par22">Interestingly, the CD62L<sup>+</sup> CD122<sup>+</sup> population in tumor draining lymph nodes (TDLN) were increased in the CATP group (Fig. <a href="#Fig6" class="usa-link">6d</a>). The CD62L is highly expressed on the naïve CD8 T cells and memory CD8 T cells and CD62L on most of the CD8 T cells are decreased after CD8 T cells activations. The CD122<sup>+</sup> CD8 T cells are considered as a new regulator with central memory phenotypes highly expressing CD62L<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. The increased CD62L<sup>+</sup> CD122<sup>+</sup> populations in the CATP group in TDLN are likely the memory precursors against the tumor antigens. Other CD62L<sup>+</sup> CD122<sup>+</sup> populations in the PBS group in TDLN are likely the memory precursors against various other antigens. In consistent with such kind of hypothesis, the CD62L<sup>+</sup> CD122<sup>+</sup> populations in various groups in spleen are comparable (Fig. <a href="#Fig6" class="usa-link">6e</a>). The further evidence is the activated CD8 T cells are comparable in different groups either in TDLN or spleen ((Fig. <a href="#Fig6" class="usa-link">6d, e</a>).</p>
<p id="Par23">In conclusion, the CATP system represents a groundbreaking advancement in cancer therapy, effectively addressing critical challenges in payload delivery and therapeutic efficacy. Its innovative dual-amplification strategy, combined with its safety and adaptability, establishes a transformative platform for the development of next-generation cancer immunotherapies. By enabling robustly higher payload expression without exacerbating systemic toxicity, the CATP platform holds significant potential to reshape clinical practice, revolutionize the treatment landscape across a wide range of malignancies, and promote durable immune memory for sustained therapeutic benefits.</p></section><section id="Sec10"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec11"><h3 class="pmc_sec_title">Constructs, in vitro transcription, capping/methylating for self-amplifying mRNA (SamRNA) and modified mRNA</h3>
<p id="Par24">VEE SamRNA plasmid DNA was de novo synthesized based on the viral sequences of the VEE-TC-83 strain (Genebank ID: <a href="https://www.ncbi.nlm.nih.gov/nuccore/L01443.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">L01443.1</a>) and prepared based on the constructs previously developed in the WO2023220693A1, “Synthetic SamRNA Molecules with Secretion Antigen and Immunomodulator”. Modified mRNA plasmid DNA was prepared based on the constructs previously developed in the PCT/US2023/085919, “Compositions and Methods for Delivering Molecules”.</p>
<p id="Par25">eGFP, firefly luciferase, mouse IL-12, and mouse IL-18 were cloned into XbaI and ClaI after the subgenomic promoter of VEE SamRNA plasmid DNA. Capsids/envelops from Venezuelan equine encephalitis virus (VEE), Sindbis virus, and Semliki Forest virus (SFV) 4 were cloned after T7 promoter using seamless cloning technology.</p>
<p id="Par26">SamRNA were in vitro transcribed (IVT) from the templates of linearized VEE DNA constructs using the NEB RNA synthesize kit (Catalog No. E2050S). Then the synthesized mRNAs were capped and methylated by Cellscript kits (Catalog No. C-SCCS1710). Modified mRNAs were in vitro transcribed (IVT) from the templates of linearized VEE DNA constructs using the NEB RNA synthesize kit (Catalog No. E2040S) plus pseudouridine (Catalog No. N-1019) and Cleancap (Catalog No. N-7413) from Trilink. The quantity and purity of SamRNA and modified mRNA were assessed by Nanodrop and gel electrophoresis.</p></section><section id="Sec12"><h3 class="pmc_sec_title">Formulations of lipid nanoparticles and encapsulation of SamRNA and modified mRNA</h3>
<p id="Par27">P6 ionizable lipid was designed and synthesized as in the patent (WO2025010420A2). Delivery efficiency of P6-LNP-SamRNA (EGFP) was evaluated by 293 cells and the formulations were optimized using an orthogonal experimental design. As illustrated and data in Supplementary Fig. <a href="#MOESM2" class="usa-link">6a–f</a>, four concentration levels were evaluated for each of the four key components: P6, DOPE, cholesterol, and DMG-PEG<sub>2000</sub>. This approach enabled systematic assessment of individual and interactive effects using only 16 experimental conditions, representing a significant reduction from the 256 possible combinations in a full factorial design.The predicted optimal formulation was identified as P6 /DOPE /Chol /DMG -PEG2000 = 30/15/50/1.5 (referred to as “Opt”). The Opt formulation was subsequently evaluated based on its EGFP expression level in HEK293 cells (Supplementary Fig. <a href="#MOESM2" class="usa-link">6b</a>), demonstrating the highest delivery efficiency among all tested conditions.</p>
<p id="Par28">An ethanol phase was prepared by dissolving P6 (Supplementary Fig. <a href="#MOESM2" class="usa-link">7a</a>), DOPE (Catalog No. 870341, Avanti Research), cholesterol (Catalog No. 7001, Avanti Research), and DMG-PEG<sub>2000</sub> (Catalog No. 880151, Avanti Research) at a predetermined molar ratio of 30:15:50:1.5 for P6-LNPs and SM102 (Catalog No. <a href="https://www.ncbi.nlm.nih.gov/nuccore/HH119909" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">HH119909</a>, Arctom Scientific), DSPC (Catalog No. 850333, Avanti Research), cholesterol (Catalog No. 7001, Avanti Research) and DMG-PEG<sub>2000</sub> (Catalog No. 880151, Avanti Research) at a molar ratio of 50:10:38.5:1.5 for SM102-LNPs at finally total lipids concentration is at 10 mg/ml. The aqueous phase was prepared in 50 mM citrate buffer (pH 4.5, AAJ60024AK, Fisher Scientific) containing SamRNA and/or mRNA. All mRNA samples were stored at −80 °C and thawed on ice prior to use. The aqueous and ethanol phases were combined at a 3:1 ratio with a lipid-to-RNA (N/P) ratio of 4.2 for P6-LNPs and 6 for SM102-LNPs, respectively, using a microfluidic chip device (INano™ L system, Micro &amp; Nano) at a flow rate of 12 mL/min. The resulting lipid nanoparticles (LNPs) were dialyzed against 1X PBS (MT21040CMX, Fisher Scientific) using a Slide-A-Lyzer™ MINI Dialysis Devices, 20 K MWCO (Catalog No. 88405 Fisher Scientific) at 25 °C for 80 min and stored at 4 °C prior to injection.</p></section><section id="Sec13"><h3 class="pmc_sec_title">Characterization of ionizable lipid N-(2-(cyclohex-1-en-1-ylamino)-1-(1-ethylpiperidin-4-yl)-2-oxoethyl)-N-(heptadecan-9-yl)palmitamide (P6)</h3>
<p id="Par29">QTOF MS (ESI): m/z calculated for C<sub>48</sub>H<sub>92</sub>N<sub>3</sub>O<sub>2</sub><sup>+</sup> (M + H<sup>+</sup>), 742.7185; found, 742.7156. <sup>1</sup>H NMR (400 MHz, CDCl3) δ 9.47 (s, 1H), 6.07 (s, 1H), 3.55 (s, 1H), 3.15 (d, J = 8.0 Hz, 1H), 3.08 (s, 2H), 2.73 (s, 1H), 2.52 (s, 2H), 2.36–2.31 (m, 2H), 2.07–2.04 (m, 6H), 1.83–1.79 (m, 2H), 1.66–1.15 (m, 60H), 0.89–0.79 (m, 12H). <sup>13</sup>C NMR (400 MHz, CDCl3) δ 175.97, 170.26, 132.75, 112.15, 60.44, 52.81, 52.67, 52.48, 35.05, 34.06, 32.29, 32.01, 31.90, 29.85, 29.79, 29.78, 29.74, 29.69, 29.57, 29.53, 29.44, 29.37, 29.28, 28.16, 27.29, 27.10, 25.45, 24.05, 22.77, 22.74, 22.72, 22.61, 22.18, 14.19, 14.18.</p></section><section id="Sec14"><h3 class="pmc_sec_title">LNP characterization</h3>
<p id="Par30">The size, polydispersity index and zeta potentials of LNPs were measured using dynamic light scattering (Z-100-Z2(MTS), HORIBA, Ltd.). Diameters are reported as the intensity mean peak average. To calculate the nucleic acid encapsulation efficiency, a modified Quant-iT RiboGreen RNA assay (Invitrogen) was used. Results of encapsulation efficiency can be found in the Supplementary Fig. <a href="#MOESM2" class="usa-link">7b</a>.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Stability evaluation of P6-LNPs</h3>
<p id="Par31">The formulated LNPs (P6-LNP-SamRNA (eGFP) and SM102-LNP-SamRNA (eGFP)) were buffer changed with Tris HCl buffer (20 mM, pH 7.5, 8.5% sucrose w/w) and stored at 4 °C. The in vitro transfection efficiency of the LNPs were evaluated using HEK293 after 2, 6, 10 and 20 weeks (Supplementary Fig. <a href="#MOESM2" class="usa-link">8</a>).</p>
<p id="Par32">To address the in vivo stability and the resistances of RNase, the formulated LNPs, P6-LNP-SamRNA (Luciferase) and P6-LNP-modified mRNA (Luciferase) were administrated by intramuscularly or intravenously. The images of bioluminescence were measured by IVIS (In vitro imaging system) (Supplementary Fig. <a href="#MOESM2" class="usa-link">9</a>).</p>
<p id="Par33">To address the effects of the serum to the formulated LNPs, fetal bovine serum was filtered through 0.22 mm filter and the flowthrough was incubated with LNPs for two hours. Then the nanoparticles size was measured (Supplementary Fig. <a href="#MOESM2" class="usa-link">10</a>).</p></section><section id="Sec16"><h3 class="pmc_sec_title">Transfections of lipid nanoparticles in vitro and in vivo</h3>
<p id="Par34">For in vitro transfection, the cells were plated at 30% confluence at day 0. The formulated nanoparticles containing 100 ng mRNA were added to 100 μl of medium in a well of a 96-well plate at day 1. Then the transfected cells were followed with analysis accordingly.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Cell lines and animals</h3>
<p id="Par35">Cell lines HEK293 (ATCC CRL-1573), B16F10 (ATCC CRL-6475), CT26 (ATCC CRL-2638), were cultured following vendor instructions. MC38 and KPC (<em>P53</em><sup><em>null</em></sup>
<em>KRas</em><sup><em>G12D</em></sup>) cells were prepared in the Li lab at the University of Michigan. All the cells into mice were performed with pathogen tests by third party as Mispro Biotech Service Corporation requires. The identity of cells into mice were determined by morphological records and tumor growth rates which were described by providers. Female C57BL/6 (Charles River Lab), Balb/C (Charles River Lab) mice at 6–8 weeks of age were purchased and maintained in the animal facility at the Mispro Biotech Service Corporation, Alewife, Massachusetts, USA. We have complied with all relevant ethical regulations for animal use. All animal studies and procedures were carried out following federal, state and local guidelines under an institutional animal care and use committee (IACUC)-approved animal protocols (2022-SUN-01, and 2024-SUN-02) by the Committee of Animal Care at Mispro Biotech Service Corporation. The IACUC of the Mispro Biotech Service Corporation approved all animal experiments and all animal experiments were conducted at the Mispro Biotech Service Corporation.</p>
<p id="Par36">Tumor inoculation, tumor therapy, and rechallenge. One million B16F10, MC38, CT26 or KPC (<em>P53</em><sup><em>null</em></sup>
<em>KRas</em><sup><em>G12D</em></sup>) cells in 50 μl of sterile PBS were s.c. injected into the flank of mice. At 7 days later when tumors reached ~50 mm<sup>2</sup> in size, animals were injected intratumorally with PBS (control) or LNPs as described in figure legends in 50 μl of PBS as indicated. For the rechallenge, 0.1 million B16F10 or 0.2 million MC38 cancer cells were subcutaneously (s.c.) injected into another side flank of fully tumor regressed mice or naïve mice.</p>
<p id="Par37">The tumor areas were used for tumor growth regression as the statistic differences observed by tumor area was more reliable though with lower sensitivity than by tumor volume<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. The tumor area was determined by the width x length which was measured by caliper. The maximal tumor volumes that were permitted by the IACUC of Mispro Biotech Service Corporation were not exceeded in any of the animal experiments. All the tumor mice were followed with the endpoints (e.g., tumor size no more than 20 mm in diameter, or body condition score (BCS &lt; 2), or weight loss &gt;20% etc.) which were described in the IACUC animal protocol approved (2022-SUN-01, and 2024-SUN-02).</p></section><section id="Sec18"><h3 class="pmc_sec_title">Antibodies, staining and FACS analysis</h3>
<p id="Par38">Antibodies against mouse CD4 (Catalog No. 100412), CD8 (Catalog No. 100766), CD3e (Catalog No. 155612), CD62L (Catalog No. 104406), CD122 (Catalog No. 123216), KLRG1 (Catalog No. 138418), 7-AAD (Catalog No. 420404), and Zombie Aqua (Catalog No. 423102) were bought from Biolegend. All the antibodies were diluted 1:50. The live/dead dye Zombie Aqua was diluted 1:300. The single-cell suspensions were filtered by 70-μm nylon strainers and stained as described<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. Stained samples were analyzed using a Symphony A5 FACS analyzer from BD Biosciences. All flow cytometry data were analyzed using FlowJo software (Flowjo LLC).</p></section><section id="Sec19"><h3 class="pmc_sec_title">ELISA analysis</h3>
<p id="Par39">Tumors were collected and ground in tissue protein extraction reagent (T-PER<sup>TM</sup>, Thermo Fisher Scientific, cat. no. 78510) in the presence of 1% proteinase and phosphatase inhibitors (Thermo Fisher Scientific, cat. no. 78442). The lysates were incubated at 4 °C for 30 min with slow rotation then centrifuged to remove debris. The supernatants were transferred to a clean tube for ELISA or Luminex analysis. Mouse IL-12 in tumor tissue supernatants or in serum were measured by ELISA kits from R&amp;D (Catalog No. DY419) following the manufacturer’s instructions.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Plots</h3>
<p id="Par40">Plots were drawn by Prism and the illustrations Figs. <a href="#Fig1" class="usa-link">1a</a> and <a href="#Fig3" class="usa-link">3d</a> were created in BioRender. Li, Y. (2025) <a href="https://BioRender.com/g50p020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/g50p020</a>” and <a href="https://BioRender.com/bguaszo" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://BioRender.com/bguaszo</a>”, respectively.</p></section><section id="Sec21"><h3 class="pmc_sec_title">Statistics and reproducibility</h3>
<p id="Par41">Data were statistically analyzed by one-way or two-way ANOVA or by Student’s <em>t</em>-test using GraphPad PRISM as indicated. Animals were randomized to treatment groups once the mean tumor area around 50 mm<sup>2</sup> was reached by the tumor-inoculated cohort. No data were excluded from the analyses. The investigators were not blinded to allocation during experiments and outcome assessments. The samples sizes for in vitro analysis were three (triplicates) and for in vivo analysis are as annotated in figure legends. The details of statistical analysis for figures and Extended Data Figures are included in the Source Data files. The sample size in animal studies were determined by “E = Total number of animals—Total number of groups” which lies in 10–20 that’s enough for ANOVA analysis<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a></sup>. The allocations of experimental units to control and treatment groups are random but not blindly by selection of cages for treatments as indicated.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Reporting summary</h3>
<p id="Par42">Further information on research design is available in the <a href="#MOESM5" class="usa-link">Nature Portfolio Reporting Summary</a> linked to this article.</p></section></section><section id="Sec23"><h2 class="pmc_sec_title">Supplementary information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Transparent Peer Review file</a><sup> (707.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (973.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">42003_2025_8735_MOESM3_ESM.pdf</a><sup> (38.1KB, pdf) </sup><p>Description of Additional Supplementary Files</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 1</a><sup> (3.3MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting summary</a><sup> (2MB, pdf) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>We’d like to thank lots of persons for their generous helps to make this work happened, especially to thank Claire Johnson and Ana Lopez from Mispro Biotech Service Corporation for their kindly helps on drafting animal protocols and mouse maintenance, respectively. We’d like to thank our seeding investors for their continuous funding support and many advice. We’d like to thank Tom Shea and his team from Xentria for many thoughtful discussions on this work.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Y.L. conceptualized, designed the experiments and L.Z. designed the ionizable lipid and LNP formulation. Y.L., J.W., N.L., M.W., and L.Z., carried out the experiments. J.L. and Z.W. prepared MC38 colon cancer and <em>P53</em><sup><em>null</em></sup>
<em>KRas</em><sup><em>G12D</em></sup> pancreatic duct cancer cell lines. Y.L., L.Z., and J.W. organized and drafted the manuscript. J.L. edited the manuscript. All authors read, edited, and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Peer review</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Peer review information</h3>
<p id="Par43"><em>Communications Biology</em> thanks Rakesh Kumar Tekade and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editors: Huan Bao and Johannes Stortz. [A peer review file is available].</p></section></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The source data behind the graphs in the paper can be found in Supplementary Data <a href="#MOESM4" class="usa-link">1</a> and other data (e.g., synthesis of lipids and plasmids) are available from the corresponding authors upon reasonable request, maybe under non-disclosure agreement (NDA) or material transferring agreement (MTA).</p></section><section id="FPar2"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par44">Y.L. and L.Z. are inventors patent of WO2025010420A2 “Compositions and methods for delivering molecules”, which invented the mRNA delivery ionizable lipid P6 for this study; patent of WO2023220693A1 “Synthetic self-amplifying mRNA molecules with secretion antigen and immunomodulator”, which invented one of the self-amplifying mRNA for this study; patent of Methods for cascade amplifications of PCT/US2025/019051 “Therapeutic payloads (CATP) &amp; compositions for cancer immunotherapies and gene therapy” for this study. The other authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Yingzhong Li, Email: yingzhongli@sunvaxmrna.com.</p>
<p>Libin Zhang, Email: libinzhang@sunvaxmrna.com.</p></section><section id="sec24"><h2 class="pmc_sec_title">Supplementary information</h2>
<p>The online version contains supplementary material available at 10.1038/s42003-025-08735-z.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Bloom, K., van den Berg, F. &amp; Arbuthnot, P. Self-amplifying RNA vaccines for infectious diseases. <em>Gene Ther.</em><strong>28</strong>, 117–129 (2021).
</cite> [<a href="https://doi.org/10.1038/s41434-020-00204-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7580817/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33093657/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bloom,%20K.,%20van%20den%20Berg,%20F.%20&amp;%20Arbuthnot,%20P.%20Self-amplifying%20RNA%20vaccines%20for%20infectious%20diseases.%20Gene%20Ther.28,%20117%E2%80%93129%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Comes, J. D. G., Pijlman, G. P. &amp; Hick, T. A. H. Rise of the RNA machines—self-amplification in mRNA vaccine design. <em>Trends Biotechnol.</em><strong>41</strong>, 1417–1429 (2023).
</cite> [<a href="https://doi.org/10.1016/j.tibtech.2023.05.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10266560/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37328401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Comes,%20J.%20D.%20G.,%20Pijlman,%20G.%20P.%20&amp;%20Hick,%20T.%20A.%20H.%20Rise%20of%20the%20RNA%20machines%E2%80%94self-amplification%20in%20mRNA%20vaccine%20design.%20Trends%20Biotechnol.41,%201417%E2%80%931429%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Kariko, K., Ni, H., Capodici, J., Lamphier, M. &amp; Weissman, D. mRNA is an endogenous ligand for Toll-like receptor 3. <em>J. Biol. Chem.</em><strong>279</strong>, 12542–12550 (2004).
</cite> [<a href="https://doi.org/10.1074/jbc.M310175200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14729660/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kariko,%20K.,%20Ni,%20H.,%20Capodici,%20J.,%20Lamphier,%20M.%20&amp;%20Weissman,%20D.%20mRNA%20is%20an%20endogenous%20ligand%20for%20Toll-like%20receptor%203.%20J.%20Biol.%20Chem.279,%2012542%E2%80%9312550%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Teijaro, J. R. &amp; Farber, D. L. COVID-19 vaccines: modes of immune activation and future challenges. <em>Nat. Rev. Immunol.</em><strong>21</strong>, 195–197 (2021).
</cite> [<a href="https://doi.org/10.1038/s41577-021-00526-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7934118/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33674759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Teijaro,%20J.%20R.%20&amp;%20Farber,%20D.%20L.%20COVID-19%20vaccines:%20modes%20of%20immune%20activation%20and%20future%20challenges.%20Nat.%20Rev.%20Immunol.21,%20195%E2%80%93197%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Kariko, K., Buckstein, M., Ni, H. &amp; Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. <em>Immunity</em><strong>23</strong>, 165–175 (2005).
</cite> [<a href="https://doi.org/10.1016/j.immuni.2005.06.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16111635/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kariko,%20K.,%20Buckstein,%20M.,%20Ni,%20H.%20&amp;%20Weissman,%20D.%20Suppression%20of%20RNA%20recognition%20by%20Toll-like%20receptors:%20the%20impact%20of%20nucleoside%20modification%20and%20the%20evolutionary%20origin%20of%20RNA.%20Immunity23,%20165%E2%80%93175%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Schuberth-Wagner, C. et al. A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2’O-methylated self RNA. <em>Immunity</em><strong>43</strong>, 41–51 (2015).
</cite> [<a href="https://doi.org/10.1016/j.immuni.2015.06.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7128463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26187414/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schuberth-Wagner,%20C.%20et%20al.%20A%20conserved%20histidine%20in%20the%20RNA%20sensor%20RIG-I%20controls%20immune%20tolerance%20to%20N1-2%E2%80%99O-methylated%20self%20RNA.%20Immunity43,%2041%E2%80%9351%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Dias Junior, A. G., Sampaio, N. G. &amp; Rehwinkel, J. A balancing act: MDA5 in antiviral immunity and autoinflammation. <em>Trends Microbiol</em><strong>27</strong>, 75–85 (2019).
</cite> [<a href="https://doi.org/10.1016/j.tim.2018.08.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6319154/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30201512/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dias%20Junior,%20A.%20G.,%20Sampaio,%20N.%20G.%20&amp;%20Rehwinkel,%20J.%20A%20balancing%20act:%20MDA5%20in%20antiviral%20immunity%20and%20autoinflammation.%20Trends%20Microbiol27,%2075%E2%80%9385%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Andries, O. et al. N(1)-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice. <em>J. Control Release</em><strong>217</strong>, 337–344 (2015).
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2015.08.051" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26342664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andries,%20O.%20et%20al.%20N(1)-methylpseudouridine-incorporated%20mRNA%20outperforms%20pseudouridine-incorporated%20mRNA%20by%20providing%20enhanced%20protein%20expression%20and%20reduced%20immunogenicity%20in%20mammalian%20cell%20lines%20and%20mice.%20J.%20Control%20Release217,%20337%E2%80%93344%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Wang, J. et al. Quantifying the RNA cap epitranscriptome reveals novel caps in cellular and viral RNA. <em>Nucleic Acids Res.</em><strong>47</strong>, e130 (2019).
</cite> [<a href="https://doi.org/10.1093/nar/gkz751" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6847653/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31504804/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20J.%20et%20al.%20Quantifying%20the%20RNA%20cap%20epitranscriptome%20reveals%20novel%20caps%20in%20cellular%20and%20viral%20RNA.%20Nucleic%20Acids%20Res.47,%20e130%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Amer, S. A. et al. Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study. <em>Sci. Rep.</em><strong>14</strong>, 4785 (2024).
</cite> [<a href="https://doi.org/10.1038/s41598-024-54886-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10899622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38413637/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Amer,%20S.%20A.%20et%20al.%20Exploring%20the%20reported%20adverse%20effects%20of%20COVID-19%20vaccines%20among%20vaccinated%20Arab%20populations:%20a%20multi-national%20survey%20study.%20Sci.%20Rep.14,%204785%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Bitounis, D., Jacquinet, E., Rogers, M. A. &amp; Amiji, M. M. Strategies to reduce the risks of mRNA drug and vaccine toxicity. <em>Nat. Rev. Drug Discov.</em><strong>23</strong>, 281–300 (2024).
</cite> [<a href="https://doi.org/10.1038/s41573-023-00859-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38263456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bitounis,%20D.,%20Jacquinet,%20E.,%20Rogers,%20M.%20A.%20&amp;%20Amiji,%20M.%20M.%20Strategies%20to%20reduce%20the%20risks%20of%20mRNA%20drug%20and%20vaccine%20toxicity.%20Nat.%20Rev.%20Drug%20Discov.23,%20281%E2%80%93300%20(2024)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Li, Y. et al. Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity. <em>Nat. Cancer</em><strong>1</strong>, 882–893 (2020).
</cite> [<a href="https://doi.org/10.1038/s43018-020-0095-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8386348/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34447945/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20Y.%20et%20al.%20Multifunctional%20oncolytic%20nanoparticles%20deliver%20self-replicating%20IL-12%20RNA%20to%20eliminate%20established%20tumors%20and%20prime%20systemic%20immunity.%20Nat.%20Cancer1,%20882%E2%80%93893%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Hewitt, S. L. et al. Intratumoral IL12 mRNA therapy promotes TH1 transformation of the tumor microenvironment. <em>Clin. Cancer Res</em><strong>26</strong>, 6284–6298 (2020).
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-20-0472" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32817076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hewitt,%20S.%20L.%20et%20al.%20Intratumoral%20IL12%20mRNA%20therapy%20promotes%20TH1%20transformation%20of%20the%20tumor%20microenvironment.%20Clin.%20Cancer%20Res26,%206284%E2%80%936298%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Hotz, C. et al. Local delivery of mRNA-encoded cytokines promotes antitumor immunity and tumor eradication across multiple preclinical tumor models. <em>Sci. Transl. Med.</em><strong>13</strong>, eabc7804 (2021).
</cite> [<a href="https://doi.org/10.1126/scitranslmed.abc7804" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34516826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hotz,%20C.%20et%20al.%20Local%20delivery%20of%20mRNA-encoded%20cytokines%20promotes%20antitumor%20immunity%20and%20tumor%20eradication%20across%20multiple%20preclinical%20tumor%20models.%20Sci.%20Transl.%20Med.13,%20eabc7804%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Vignuzzi, M. &amp; Lopez, C. B. Defective viral genomes are key drivers of the virus-host interaction. <em>Nat. Microbiol</em><strong>4</strong>, 1075–1087 (2019).
</cite> [<a href="https://doi.org/10.1038/s41564-019-0465-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7097797/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31160826/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vignuzzi,%20M.%20&amp;%20Lopez,%20C.%20B.%20Defective%20viral%20genomes%20are%20key%20drivers%20of%20the%20virus-host%20interaction.%20Nat.%20Microbiol4,%201075%E2%80%931087%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Overwijk, W. W. &amp; Restifo, N. P. B16 as a mouse model for human melanoma. <em>Curr. Protoc. Immunol.</em><strong>Chapter 20</strong>, Unit 20 21 10.1002/0471142735.im2001s39 (2001).</cite> [<a href="https://doi.org/10.1002/0471142735.im2001s39" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2763508/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18432774/" class="usa-link">PubMed</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Melero, I., Castanon, E., Alvarez, M., Champiat, S. &amp; Marabelle, A. Intratumoural administration and tumour tissue targeting of cancer immunotherapies. <em>Nat. Rev. Clin. Oncol.</em><strong>18</strong>, 558–576 (2021).
</cite> [<a href="https://doi.org/10.1038/s41571-021-00507-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8130796/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34006998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Melero,%20I.,%20Castanon,%20E.,%20Alvarez,%20M.,%20Champiat,%20S.%20&amp;%20Marabelle,%20A.%20Intratumoural%20administration%20and%20tumour%20tissue%20targeting%20of%20cancer%20immunotherapies.%20Nat.%20Rev.%20Clin.%20Oncol.18,%20558%E2%80%93576%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Lasek, W., Zagozdzon, R. &amp; Jakobisiak, M. Interleukin 12: still a promising candidate for tumor immunotherapy. <em>Cancer Immunol. Immunother.</em><strong>63</strong>, 419–435 (2014).
</cite> [<a href="https://doi.org/10.1007/s00262-014-1523-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3994286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24514955/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lasek,%20W.,%20Zagozdzon,%20R.%20&amp;%20Jakobisiak,%20M.%20Interleukin%2012:%20still%20a%20promising%20candidate%20for%20tumor%20immunotherapy.%20Cancer%20Immunol.%20Immunother.63,%20419%E2%80%93435%20(2014)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Wang, J., Saffold, S., Cao, X., Krauss, J. &amp; Chen, W. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines. <em>J. Immunol.</em><strong>161</strong>, 5516–5524 (1998).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/9820528/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20J.,%20Saffold,%20S.,%20Cao,%20X.,%20Krauss,%20J.%20&amp;%20Chen,%20W.%20Eliciting%20T%20cell%20immunity%20against%20poorly%20immunogenic%20tumors%20by%20immunization%20with%20dendritic%20cell-tumor%20fusion%20vaccines.%20J.%20Immunol.161,%205516%E2%80%935524%20(1998)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Jose, J., Snyder, J. E. &amp; Kuhn, R. J. A structural and functional perspective of alphavirus replication and assembly. <em>Future Microbiol.</em><strong>4</strong>, 837–856 (2009).
</cite> [<a href="https://doi.org/10.2217/fmb.09.59" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2762864/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19722838/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jose,%20J.,%20Snyder,%20J.%20E.%20&amp;%20Kuhn,%20R.%20J.%20A%20structural%20and%20functional%20perspective%20of%20alphavirus%20replication%20and%20assembly.%20Future%20Microbiol.4,%20837%E2%80%93856%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Ramachandran, M. et al. Safe and effective treatment of experimental neuroblastoma and glioblastoma using systemically delivered triple MicroRNA-detargeted oncolytic Semliki Forest virus. <em>Clin. Cancer Res</em><strong>23</strong>, 1519–1530 (2017).
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-16-0925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27637889/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ramachandran,%20M.%20et%20al.%20Safe%20and%20effective%20treatment%20of%20experimental%20neuroblastoma%20and%20glioblastoma%20using%20systemically%20delivered%20triple%20MicroRNA-detargeted%20oncolytic%20Semliki%20Forest%20virus.%20Clin.%20Cancer%20Res23,%201519%E2%80%931530%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Ihim, S. A. et al. Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment. <em>Front Immunol.</em><strong>13</strong>, 919973 (2022).
</cite> [<a href="https://doi.org/10.3389/fimmu.2022.919973" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9410767/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36032110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ihim,%20S.%20A.%20et%20al.%20Interleukin-18%20cytokine%20in%20immunity,%20inflammation,%20and%20autoimmunity:%20Biological%20role%20in%20induction,%20regulation,%20and%20treatment.%20Front%20Immunol.13,%20919973%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Lucey, D. R., Clerici, M. &amp; Shearer, G. M. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. <em>Clin. Microbiol. Rev.</em><strong>9</strong>, 532–562 (1996).
</cite> [<a href="https://doi.org/10.1128/cmr.9.4.532" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC172909/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8894351/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lucey,%20D.%20R.,%20Clerici,%20M.%20&amp;%20Shearer,%20G.%20M.%20Type%201%20and%20type%202%20cytokine%20dysregulation%20in%20human%20infectious,%20neoplastic,%20and%20inflammatory%20diseases.%20Clin.%20Microbiol.%20Rev.9,%20532%E2%80%93562%20(1996)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Zhou, T. et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy. <em>Nature</em><strong>583</strong>, 609–614 (2020).
</cite> [<a href="https://doi.org/10.1038/s41586-020-2422-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7381364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32581358/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhou,%20T.%20et%20al.%20IL-18BP%20is%20a%20secreted%20immune%20checkpoint%20and%20barrier%20to%20IL-18%20immunotherapy.%20Nature583,%20609%E2%80%93614%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Kim, S. H. et al. Site-specific mutations in the mature form of human IL-18 with enhanced biological activity and decreased neutralization by IL-18 binding protein. <em>Proc. Natl. Acad. Sci. USA</em><strong>98</strong>, 3304–3309 (2001).
</cite> [<a href="https://doi.org/10.1073/pnas.051634098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC30649/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11248074/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim,%20S.%20H.%20et%20al.%20Site-specific%20mutations%20in%20the%20mature%20form%20of%20human%20IL-18%20with%20enhanced%20biological%20activity%20and%20decreased%20neutralization%20by%20IL-18%20binding%20protein.%20Proc.%20Natl.%20Acad.%20Sci.%20USA98,%203304%E2%80%933309%20(2001)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Hingorani, S. R. et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. <em>Cancer Cell</em><strong>7</strong>, 469–483 (2005).
</cite> [<a href="https://doi.org/10.1016/j.ccr.2005.04.023" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15894267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hingorani,%20S.%20R.%20et%20al.%20Trp53R172H%20and%20KrasG12D%20cooperate%20to%20promote%20chromosomal%20instability%20and%20widely%20metastatic%20pancreatic%20ductal%20adenocarcinoma%20in%20mice.%20Cancer%20Cell7,%20469%E2%80%93483%20(2005)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Yang, S., Liu, F., Wang, Q. J., Rosenberg, S. A. &amp; Morgan, R. A. The shedding of CD62L (L-selectin) regulates the acquisition of lytic activity in human tumor reactive T lymphocytes. <em>PLoS One</em><strong>6</strong>, e22560 (2011).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0022560" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3145643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21829468/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang,%20S.,%20Liu,%20F.,%20Wang,%20Q.%20J.,%20Rosenberg,%20S.%20A.%20&amp;%20Morgan,%20R.%20A.%20The%20shedding%20of%20CD62L%20(L-selectin)%20regulates%20the%20acquisition%20of%20lytic%20activity%20in%20human%20tumor%20reactive%20T%20lymphocytes.%20PLoS%20One6,%20e22560%20(2011)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Liu, J., Chen, D., Nie, G. D. &amp; Dai, Z. CD8(+)CD122(+) T-cells: a newly emerging regulator with central memory cell phenotypes. <em>Front Immunol.</em><strong>6</strong>, 494 (2015).
</cite> [<a href="https://doi.org/10.3389/fimmu.2015.00494" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4610204/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26539191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20J.,%20Chen,%20D.,%20Nie,%20G.%20D.%20&amp;%20Dai,%20Z.%20CD8(+)CD122(+)%20T-cells:%20a%20newly%20emerging%20regulator%20with%20central%20memory%20cell%20phenotypes.%20Front%20Immunol.6,%20494%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Herndler-Brandstetter, D. et al. KLRG1(+) effector CD8(+) T cells lose KLRG1, differentiate into all memory T cell lineages, and convey enhanced protective. <em>Immun. Immun.</em><strong>48</strong>, 716–729 e718 (2018).</cite> [<a href="https://doi.org/10.1016/j.immuni.2018.03.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6465538/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29625895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Herndler-Brandstetter,%20D.%20et%20al.%20KLRG1(+)%20effector%20CD8(+)%20T%20cells%20lose%20KLRG1,%20differentiate%20into%20all%20memory%20T%20cell%20lineages,%20and%20convey%20enhanced%20protective.%20Immun.%20Immun.48,%20716%E2%80%93729%20e718%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Momin, N. et al. Anchoring of intratumorally administered cytokines to collagen safely potentiates systemic cancer immunotherapy. <em>Sci. Transl. Med.</em><strong>11</strong>10.1126/scitranslmed.aaw2614 (2019).</cite> [<a href="https://doi.org/10.1126/scitranslmed.aaw2614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7811803/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31243150/" class="usa-link">PubMed</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Ghoneim, H. E., Zamora, A. E., Thomas, P. G. &amp; Youngblood, B. A. Cell-intrinsic barriers of T cell-based immunotherapy. <em>Trends Mol. Med.</em><strong>22</strong>, 1000–1011 (2016).
</cite> [<a href="https://doi.org/10.1016/j.molmed.2016.10.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5135632/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27825667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ghoneim,%20H.%20E.,%20Zamora,%20A.%20E.,%20Thomas,%20P.%20G.%20&amp;%20Youngblood,%20B.%20A.%20Cell-intrinsic%20barriers%20of%20T%20cell-based%20immunotherapy.%20Trends%20Mol.%20Med.22,%201000%E2%80%931011%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Yi, J. S., Cox, M. A. &amp; Zajac, A. J. T-cell exhaustion: characteristics, causes and conversion. <em>Immunology</em><strong>129</strong>, 474–481 (2010).
</cite> [<a href="https://doi.org/10.1111/j.1365-2567.2010.03255.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2842494/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20201977/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yi,%20J.%20S.,%20Cox,%20M.%20A.%20&amp;%20Zajac,%20A.%20J.%20T-cell%20exhaustion:%20characteristics,%20causes%20and%20conversion.%20Immunology129,%20474%E2%80%93481%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Brough, D., Amos, H., Turley, K. &amp; Murkin, J. Trends in subcutaneous tumour height and impact on measurement accuracy. <em>Cancer Inf.</em><strong>22</strong>, 11769351231165181 (2023).</cite> [<a href="https://doi.org/10.1177/11769351231165181" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10126793/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37113645/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Brough,%20D.,%20Amos,%20H.,%20Turley,%20K.%20&amp;%20Murkin,%20J.%20Trends%20in%20subcutaneous%20tumour%20height%20and%20impact%20on%20measurement%20accuracy.%20Cancer%20Inf.22,%2011769351231165181%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Li, Y. et al. Persistent antigen and prolonged AKT-mTORC1 activation underlie memory CD8 T cell impairment in the absence of CD4 T cells. <em>J. Immunol.</em><strong>195</strong>, 1591–1598 (2015).
</cite> [<a href="https://doi.org/10.4049/jimmunol.1500451" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4530017/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26163589/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li,%20Y.%20et%20al.%20Persistent%20antigen%20and%20prolonged%20AKT-mTORC1%20activation%20underlie%20memory%20CD8%20T%20cell%20impairment%20in%20the%20absence%20of%20CD4%20T%20cells.%20J.%20Immunol.195,%201591%E2%80%931598%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Charan, J. &amp; Kantharia, N. D. How to calculate sample size in animal studies. <em>J. Pharm. Pharmacother.</em><strong>4</strong>, 303–306 (2013).</cite> [<a href="https://doi.org/10.4103/0976-500X.119726" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3826013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24250214/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Charan,%20J.%20&amp;%20Kantharia,%20N.%20D.%20How%20to%20calculate%20sample%20size%20in%20animal%20studies.%20J.%20Pharm.%20Pharmacother.4,%20303%E2%80%93306%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Transparent Peer Review file</a><sup> (707.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Information</a><sup> (973.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">42003_2025_8735_MOESM3_ESM.pdf</a><sup> (38.1KB, pdf) </sup><p>Description of Additional Supplementary Files</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 1</a><sup> (3.3MB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12375736/bin/42003_2025_8735_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting summary</a><sup> (2MB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The source data behind the graphs in the paper can be found in Supplementary Data <a href="#MOESM4" class="usa-link">1</a> and other data (e.g., synthesis of lipids and plasmids) are available from the corresponding authors upon reasonable request, maybe under non-disclosure agreement (NDA) or material transferring agreement (MTA).</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Communications Biology are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s42003-025-08735-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/42003_2025_Article_8735.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12375736/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12375736/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12375736%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12375736/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12375736/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12375736/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40851032/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12375736/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40851032/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12375736/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12375736/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="m96jFkxfQ98KO0Hs7hKb3V0sfmsaZ2PRtJomJeaRUbis6HfoZ7reDEezxBXLoCVi">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
